Steroids and neuroendocrine function in anorexia nervosa.

Area of Science:

• Endocrinology
• Neuroendocrinology
• Psychiatry

Background:

• Anorexia nervosa is characterized by self-induced weight loss and significant endocrine abnormalities.
• The precise mechanisms underlying hypogonadotropic hypogonadism in anorexia nervosa remain unclear.
• Alterations in the hypothalamic-pituitary-adrenal axis are also reported in anorexia nervosa.

Purpose of the Study:

• To investigate the role of endogenous opioid peptides in hypogonadotropic hypogonadism in anorexia nervosa.
• To examine the impact of estrogen on gonadotropin secretion in anorectic patients.
• To assess the function of the hypothalamic-pituitary-adrenal axis in anorexia nervosa.

Main Methods:

• Administered naloxone (opioid antagonist) to acute anorexia nervosa patients and measured LH and FSH levels.
• Administered estrogen to partially recovered anorexia nervosa patients and monitored LH and FSH responses.
• Challenged anorexia nervosa patients and controls with ACTH to evaluate adrenal steroidogenesis.

Main Results:

• Naloxone did not alter LH or FSH levels in acute anorexia nervosa patients, suggesting no opioid involvement.
• Anorectic patients exhibited abnormal LH and FSH responses to estrogen, indicating impaired feedback mechanisms.
• Anorexia nervosa patients showed normal cortisol response to ACTH but altered androstenedione production, suggesting a deficient 17-20 desmolase system.

Conclusions:

• Endogenous opioids are likely not implicated in the hypogonadotropic hypogonadism of anorexia nervosa.
• Estrogen feedback mechanisms are disrupted in anorexia nervosa, even after partial weight recovery.
• Anorexia nervosa is associated with specific alterations in adrenal steroidogenesis, pointing to a deficient 17-20 desmolase system.